<VariationArchive VariationID="3658" VariationName="NM_000229.2(LCAT):c.491_493dup (p.Arg164_Ala165insGly)" VariationType="Duplication" Accession="VCV000003658" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2015-06-27" MostRecentSubmission="2015-06-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18697" VariationID="3658">
      <GeneList>
        <Gene Symbol="LCAT" FullName="lecithin-cholesterol acyltransferase" GeneID="3931" HGNC_ID="HGNC:6522" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67939750" stop="67944120" display_start="67939750" display_stop="67944120" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67973786" stop="67978014" display_start="67973786" display_stop="67978014" Strand="-" />
          </Location>
          <OMIM>606967</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000229.2(LCAT):c.491_493dup (p.Arg164_Ala165insGly)</Name>
      <CanonicalSPDI>NC_000016.10:67942700:CGC:CGCCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67942700" stop="67942701" display_start="67942700" display_stop="67942701" variantLength="3" positionVCF="67942700" referenceAlleleVCF="G" alternateAlleleVCF="GCGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67976603" stop="67976604" display_start="67976603" display_stop="67976604" variantLength="3" positionVCF="67976603" referenceAlleleVCF="G" alternateAlleleVCF="GCGC" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009778.1" sequenceAccession="NG_009778" sequenceVersion="1" change="g.6410_6412dup">
            <Expression>NG_009778.1:g.6410_6412dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000229.2" sequenceAccession="NM_000229" sequenceVersion="2" change="c.491_493dup" MANESelect="true">
            <Expression>NM_000229.2:c.491_493dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000220.1" sequenceAccession="NP_000220" sequenceVersion="1" change="p.Arg164_Ala165insGly">
            <Expression>NP_000220.1:p.Arg164_Ala165insGly</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033098.1" sequenceAccession="NG_033098" sequenceVersion="1" change="g.30992_30994dup">
            <Expression>NG_033098.1:g.30992_30994dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67942701_67942703dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67942701_67942703dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67976604_67976606dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67976604_67976606dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA116415" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606967.0003" DB="OMIM" />
        <XRef Type="rs" ID="794726662" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000229.2(LCAT):c.491_493dup (p.Arg164_Ala165insGly) AND LCAT deficiency" Accession="RCV000003843" Version="3">
        <ClassifiedConditionList TraitSetID="962">
          <ClassifiedCondition DB="MedGen" ID="C5779633">LCAT deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1991-09-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1991-09-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-06-27" MostRecentSubmission="2015-06-27">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1681161</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="962" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2544" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lecithin Acyltransferase Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">LCAT deficiency</ElementValue>
                <XRef ID="MONDO:0018999" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16539" />
                <XRef ID="16539" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="650" DB="Orphanet" />
              <XRef ID="79293" DB="Orphanet" />
              <XRef ID="C5779633" DB="MedGen" />
              <XRef ID="MONDO:0018999" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24008" SubmissionDate="2015-06-16" DateLastUpdated="2015-06-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606967.0003_LCAT DEFICIENCY" title="LCAT, 3-BP INS_LCAT DEFICIENCY" />
        <ClinVarAccession Accession="SCV000024008" DateUpdated="2015-06-27" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1991-09-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese patient with LCAT deficiency (245900), Gotoda et al. (1991) found a 3-bp insertion in exon 4 of the LCAT gene, which was expected to cause a substantial change in the enzyme structure. The patient showed severe renal insufficiency. The 3-bp insertion introduced a glycine residue in the middle of an alpha-helical region in exon 4. Glycine has structural flexibility that is disadvantageous in the maintenance of higher protein structures. Thus, the insertion of a single glycine residue could cause alteration in the enzyme conformation that could destabilize and inactivate the LCAT molecule.</Attribute>
              <Citation>
                <ID Source="PubMed">1681161</ID>
              </Citation>
              <XRef DB="OMIM" ID="245900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LCAT" />
          </GeneList>
          <Name>LCAT, 3-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606967.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LCAT DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24008" TraitType="Disease" MappingType="Name" MappingValue="LCAT DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C5779633" Name="LCAT deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

